{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:46:30Z","timestamp":1789519590632,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vaccine.2017.02.037","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T05:00:46Z","timestamp":1488517246000},"page":"1749-1757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia"],"prefix":"10.1016","volume":"35","author":[{"given":"Gertjan H.J.","family":"Wagenvoort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester E.","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"van der Ende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J.","family":"Vlaminckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2017.02.037_b0005","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.4161\/hv.24692","article-title":"Pneumococcal vaccination of older adults: conjugate or polysaccharide?","volume":"9","author":"Fedson","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2017.02.037_b0010","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3201\/eid1811.120329","article-title":"Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands","volume":"18","author":"van Deursen","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.037_b0015","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1086\/600045","article-title":"Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome","volume":"49","author":"Jansen","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.02.037_b0020","doi-asserted-by":"crossref","first-page":"e60273","DOI":"10.1371\/journal.pone.0060273","article-title":"AGEDD Adult Pneumococcal Burden Study Team et al. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques","volume":"8","author":"Said","year":"2013","journal-title":"PLoS ONE"},{"issue":"28","key":"10.1016\/j.vaccine.2017.02.037_b0025","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1016\/j.vaccine.2016.05.002","article-title":"Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly","volume":"34","author":"van Werkhoven","year":"2016","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2017.02.037_b0030","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMra1312885","article-title":"Community-acquired pneumonia","volume":"371","author":"Musher","year":"2014","journal-title":"N Engl J Med"},{"issue":"Suppl 6","key":"10.1016\/j.vaccine.2017.02.037_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-0691.2011.03602.x","article-title":"Guidelines for the management of adult lower respiratory tract infections\u2013summary","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2017.02.037_b0040","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.vaccine.2015.12.066","article-title":"Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2\u20136 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands","volume":"34","author":"Wagenvoort","year":"2016","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2017.02.037_b0045","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1016\/j.vaccine.2010.05.030","article-title":"Clinical and economic burden of pneumococcal disease in older US adults","volume":"28","author":"Weycker","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.037_b0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10096-014-2209-5","article-title":"Bacteraemic and non-bacteraemic\/urinary antigen-positive pneumococcal community-acquired pneumonia compared","volume":"34","author":"van Mens","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2017.02.037_b0055","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1017\/S0950268810002402","article-title":"Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae","volume":"139","author":"Lin","year":"2011","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2017.02.037_b0060","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00005792-200007000-00002","article-title":"Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study","volume":"79","author":"Musher","year":"2000","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.037_b0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejim.2007.03.015","article-title":"A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia","volume":"19","author":"Jover","year":"2008","journal-title":"Eur J Int Med"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.037_b0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1474-4422(05)70288-X","article-title":"Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series","volume":"5","author":"Weisfelt","year":"2006","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.037_b0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England","volume":"65","author":"van Hoek","year":"2012","journal-title":"J Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2017.02.037_b0080","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/cid\/cis1207","article-title":"Long-term survival following pneumococcal pneumonia","volume":"56","author":"Sandvall","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2017.02.037_b0085","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/archinte.159.14.1550","article-title":"Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study","volume":"159","author":"Koivula","year":"1999","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.vaccine.2017.02.037_b0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/thx.53.3.159","article-title":"Pneumococcal serotypes and their clinical relevance","volume":"53","author":"Kalin","year":"1998","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.vaccine.2017.02.037_b0095","doi-asserted-by":"crossref","first-page":"e1000476","DOI":"10.1371\/journal.ppat.1000476","article-title":"Pneumococcal capsular polysaccharide structure predicts serotype prevalence","volume":"5","author":"Weinberger","year":"2009","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.037_b0100","doi-asserted-by":"crossref","first-page":"e1000081","DOI":"10.1371\/journal.pmed.1000081","article-title":"Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study","volume":"6","author":"Harboe","year":"2009","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.vaccine.2017.02.037_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000348","article-title":"Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project","volume":"7","author":"Johnson","year":"2010","journal-title":"PLoS Med"},{"issue":"18","key":"10.1016\/j.vaccine.2017.02.037_b0110","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2017.02.037_b0115","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/655828","article-title":"Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis","volume":"51","author":"Weinberger","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2017.02.037_b0120","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1183\/09031936.00176309","article-title":"Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia","volume":"36","author":"Lujan","year":"2010","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.vaccine.2017.02.037_b0125","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.vaccine.2015.11.048","article-title":"Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands","volume":"34","author":"Wagenvoort","year":"2016","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2017.02.037_b0130","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3201\/eid2111.140780","article-title":"Invasive pneumococcal disease 3 years after introduction of 10-valent pneumococcal conjugate vaccine, the Netherlands","volume":"21","author":"Knol","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2017.02.037_b0135","doi-asserted-by":"crossref","first-page":"e22847","DOI":"10.1371\/journal.pone.0022847","article-title":"Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths","volume":"6","author":"Yende","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2017.02.037_b0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(09)70331-7","article-title":"Role of acute infection in triggering acute coronary syndromes","volume":"10","author":"Corrales-Medina","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"9865","key":"10.1016\/j.vaccine.2017.02.037_b0145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0140-6736(12)61266-5","article-title":"Acute pneumonia and the cardiovascular system","volume":"381","author":"Corrales-Medina","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2017.02.037_b0150","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jama.2014.18229","article-title":"Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease","volume":"313","author":"Corrales-Medina","year":"2015","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.vaccine.2017.02.037_b0155","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1056\/NEJMoa041747","article-title":"Risk of myocardial infarction and stroke after acute infection or vaccination","volume":"351","author":"Smeeth","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.02.037_b0160","first-page":"1","article-title":"Serotype-specific differences in short- and longer-term mortality following invasive pneumococcal disease","author":"Hughes","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2017.02.037_b0165","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/423852","article-title":"Differences in survival, brain damage, and cerebrospinal fluid cytokine kinetics due to meningitis caused by 3 different Streptococcus pneumoniae serotypes: evaluation in humans and in 2 experimental models","volume":"190","author":"Ostergaard","year":"2004","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.02.037_b0170","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1086\/514005","article-title":"Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis","volume":"175","author":"Engelhard","year":"1997","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.02.037_b0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3201\/eid1901.120741","article-title":"Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales","volume":"19","author":"Ladhani","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2017.02.037_b0180","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1128\/JCM.00137-13","article-title":"Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae","volume":"51","author":"Sinclair","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.02.037_b0185","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.07-1322","article-title":"The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study","volume":"133","author":"Bordon","year":"2008","journal-title":"Chest"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17302402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T21:57:06Z","timestamp":1536011826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17302402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":37,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0264410X17302402"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}